DEPAKOTE ER 250 MG TABLET

Divalproex Sodium
$3.6871per EA
High Outlier

Strength

250 mg/1

Manufacturer

AbbVie Inc.

NDC

00074740113

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

1/2/2026

Active Ingredients

DIVALPROEX SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA021168

On Market Since

8/4/2000

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.9%

1Y

+4.7%

3Y

+15.4%

5Y

N/A

All

+21.3%